|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.74 EUR | -1.01% |
|
+1.99% | -21.89% |
| 07-16 | MedTech facing a three-front squeeze | ![]() |
| 07-13 | MIB breaks out above 52,700 points, strength in Inwit | AN |
Business description: Amplifon S.p.A.

- hearing aid sales (86.5%) : auditory prostheses and implants (Amplifon, Beter Horen, Miracle Ear and Sonus brands);
- services (13.5%).
At the end of 2025, the group has a network of 10,120 outlets distributed between owned stores (5,630), franchise stores (1,210) and other (3,280; including corners).
Net sales are distributed geographically as follows: Europe/Middle East/Africa (64.9), Americas (20.7%), and Asia/Pacific (14.4%).
Number of employees: 13,435
Sales by Activity: Amplifon S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Distribution and Personalization of Hearing Solutions | 1.95B | 2.12B | 2.26B | 2.41B | 2.4B |
Geographical breakdown of sales: Amplifon S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Europe, Middle-East and Africa (EMEA) | 1.39B | 1.42B | 1.49B | 1.53B | 1.55B |
Americas | 307M | 381M | 430M | 507M | 496M |
Asia Pacific (APAC) | 252M | 320M | 345M | 370M | 345M |
Corporate | - | 523K | 491K | 342K | - |
Executive Committee: Amplifon S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Enrico Vita
CEO | Chief Executive Officer | 57 | 21/10/2015 |
Gabriele Galli
DFI | Director of Finance/CFO | 57 | 28/02/2017 |
| Chief Tech/Sci/R&D Officer | - | - | |
Andrea Ciccolini
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2020 |
| Investor Relations Contact | - | - |
Composition of the Board of Directors: Amplifon S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 31/12/2010 | |
Maurizio Costa
BRD | Director/Board Member | 77 | 23/04/2007 |
Giovanni Tamburi
BRD | Director/Board Member | 72 | 16/04/2013 |
Enrico Vita
BRD | Director/Board Member | 57 | 21/10/2015 |
| Director/Board Member | 74 | 31/12/2015 | |
| Director/Board Member | 54 | 21/04/2022 | |
Lorenzo Pozza
BRD | Director/Board Member | 60 | 21/04/2022 |
Nina Cortese
BRD | Director/Board Member | 37 | 22/04/2025 |
Nicola Bedin
BRD | Director/Board Member | 49 | 22/04/2025 |
Holdings: Amplifon S.p.A.
| Name | Stocks | % | Valuation |
|---|---|---|---|
AMPLIFON S.P.A. 0.54% | 1,458,049 | 0.54% | 16 M $ |
Company details: Amplifon S.p.A.

Group companies: Amplifon S.p.A.
| Name | Category and Sector |
|---|---|
Amplifon Belgium NV
Amplifon Belgium NV Medical/Nursing ServicesHealth Services Provides personal hearing tests and equipment delivery services |
Medical/Nursing Services
|
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.01% | +1.99% | -45.32% | -66.31% | 3.26B | ||
| +1.87% | +7.19% | -16.46% | -5.91% | 175B | ||
| -0.43% | -0.80% | -7.07% | -4.05% | 106B | ||
| -0.03% | +1.47% | +4.59% | +60.25% | 59.91B | ||
| +0.66% | +0.96% | +37.56% | +53.38% | 51.95B | ||
| -1.10% | +4.10% | -12.56% | -38.37% | 43.58B | ||
| -3.21% | -3.05% | - | - | 33.65B | ||
| -1.71% | +2.25% | -8.86% | -44.23% | 29.58B | ||
| -1.16% | +1.28% | +61.67% | -6.62% | 25.31B | ||
| -1.49% | +0.85% | -3.01% | -4.60% | 21.23B | ||
| Average | -0.76% | +1.62% | +1.17% | -6.27% | 55.03B | |
| Weighted average by Cap. | +0.08% | +2.75% | -1.69% | +2.81% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMP Stock
- Company Amplifon S.p.A.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















